BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND IDH1, IDP, 3417, ENSG00000138413, IDH, PICD, O75874 AND Prognosis
1052 results:

  • 1. IL-6 significantly correlated with the prognosis in low-grade glioma and the mediating effect of immune microenvironment.
    Yang SD; Chen MZ; Yang DF; Hu SB; Zheng DD
    Medicine (Baltimore); 2024 May; 103(19):e38091. PubMed ID: 38728467
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Glioma.
    Weller M; Wen PY; Chang SM; Dirven L; Lim M; Monje M; Reifenberger G
    Nat Rev Dis Primers; 2024 May; 10(1):33. PubMed ID: 38724526
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Structural- and DTI- MRI enable automated prediction of idh Mutation Status in CNS WHO Grade 2-4 glioma patients: a deep Radiomics Approach.
    Yuan J; Siakallis L; Li HB; Brandner S; Zhang J; Li C; Mancini L; Bisdas S
    BMC Med Imaging; 2024 May; 24(1):104. PubMed ID: 38702613
    [TBL] [Abstract] [Full Text] [Related]  

  • 4.
    Ou Y; Luo H; Zhang Q; Du T; Liu R; Wang D; Chen J; Dong M; Wang Y; Yang Z; Wang X
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):144. PubMed ID: 38682183
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A multi-omics analysis-based model to predict the prognosis of low-grade gliomas.
    Du Z; Jiang Y; Yang Y; Kang X; Yan J; Liu B; Yang M
    Sci Rep; 2024 Apr; 14(1):9427. PubMed ID: 38658591
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genomic landscape of glioblastoma without idh somatic mutation in 42 cases: a comprehensive analysis using RNA sequencing data.
    Okamoto T; Mizuta R; Takahashi Y; Otani Y; Sasaki E; Horio Y; Kuroda H; Matsushita H; Date I; Hashimoto N; Masago K
    J Neurooncol; 2024 May; 167(3):489-499. PubMed ID: 38653957
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization.
    Wang W; Li T; Cheng Y; Li F; Qi S; Mao M; Wu J; Liu Q; Zhang X; Li X; Zhang L; Qi H; Yang L; Yang K; He Z; Ding S; Qin Z; Yang Y; Yang X; Luo C; Guo Y; Wang C; Liu X; Zhou L; Liu Y; Kong W; Miao J; Ye S; Luo M; An L; Wang L; Che L; Niu Q; Ma Q; Zhang X; Zhang Z; Hu R; Feng H; Ping YF; Bian XW; Shi Y
    Cancer Cell; 2024 May; 42(5):815-832.e12. PubMed ID: 38640932
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. GPR27 expression correlates with prognosis and tumor progression in gliomas.
    Cai C; Hu L; Wu K; Liu Y
    PeerJ; 2024; 12():e17024. PubMed ID: 38638156
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Molecular characterization and survival analysis of a cohort of glioblastoma, idh-wildtype.
    Dundar B; Alsawas M; Masaadeh A; Conway K; Snow AN; Sompallae RR; Bossler AD; Ma D; Lopes Abath Neto O
    Pathol Res Pract; 2024 May; 257():155272. PubMed ID: 38631135
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Very Long-term Survivorship in Pediatric DIPG: Case Report and Review of the Literature.
    Dimentberg E; Marceau MP; Lachance A; Bergeron-Gravel S; Saikali S; Crevier L; Bourget C; Hawkins C; Jabado N; Giannakouros P; Renzi S; Larouche V
    J Pediatr Hematol Oncol; 2024 May; 46(4):211-215. PubMed ID: 38573000
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness.
    Mongiardi MP; Pallini R; D'Alessandris QG; Levi A; Falchetti ML
    Expert Rev Mol Med; 2024 Apr; 26():e5. PubMed ID: 38563164
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. IQGAP3 promotes the progression of glioma as an immune and prognostic marker.
    Gao X; Ge J; Gao X; Mei NA; Su Y; Shan S; Qian W; Guan J; Zhang Z; Wang L
    Oncol Res; 2024; 32(4):659-678. PubMed ID: 38560572
    [No Abstract]    [Full Text] [Related]  

  • 13. Real-time glioblastoma tumor microenvironment assessment by SpiderMass for improved patient management.
    Zirem Y; Ledoux L; Roussel L; Maurage CA; Tirilly P; Le Rhun É; Meresse B; Yagnik G; Lim MJ; Rothschild KJ; Duhamel M; Salzet M; Fournier I
    Cell Rep Med; 2024 Apr; 5(4):101482. PubMed ID: 38552622
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Identification and Validation of a PEX5-Dependent Signature for Prognostic Prediction in Glioma.
    Qin X; Wang B; Lu X; Song Y; Wang W
    Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540734
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Hypoxia drives shared and distinct transcriptomic changes in two invasive glioma stem cell lines.
    Marallano VJ; Ughetta ME; Tejero R; Nanda S; Ramalingam R; Stalbow L; Sattiraju A; Huang Y; Ramakrishnan A; Shen L; Wojcinski A; Kesari S; Zou H; Tsankov AM; Friedel RH
    Sci Rep; 2024 Mar; 14(1):7246. PubMed ID: 38538643
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Multi-scale feature fusion for prediction of idh1 mutations in glioma histopathological images.
    Liu X; Hu W; Diao S; Abera DE; Racoceanu D; Qin W
    Comput Methods Programs Biomed; 2024 May; 248():108116. PubMed ID: 38518408
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Multiple surgical resections for progressive idh wildtype glioblastoma-is it beneficial?
    Honeyman SI; Owen WJ; Mier J; Marks K; Dassanyake SN; Wood MJ; Fairhead R; Martinez-Soler P; Jasem H; Yarlagadda A; Roach JR; Boukas A; Stacey R; Apostolopoulos V; Plaha P
    Acta Neurochir (Wien); 2024 Mar; 166(1):138. PubMed ID: 38488994
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. High-Grade Astrocytoma with Piloid Features: A Dual Institutional Review of Imaging Findings of a Novel Entity.
    Soni N; Agarwal A; Ajmera P; Mehta P; Gupta V; Vibhute M; Gubbiotti M; Mark IT; Messina SA; Mohan S; Bathla G
    AJNR Am J Neuroradiol; 2024 Apr; 45(4):468-474. PubMed ID: 38485198
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. OTUD4 promotes the progression of glioblastoma by deubiquitinating CDK1 and activating MAPK signaling pathway.
    Ci M; Zhao G; Li C; Liu R; Hu X; Pan J; Shen Y; Zhang G; Li Y; Zhang L; Liang P; Cui H
    Cell Death Dis; 2024 Mar; 15(3):179. PubMed ID: 38429268
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinicopathological and molecular landscape of 5-year idh-wild-type glioblastoma survivors: A multicentric retrospective study.
    Miele E; Anghileri E; Calatozzolo C; Lazzarini E; Patrizi S; Ciolfi A; Pedace L; Patanè M; Abballe L; Paterra R; Maddaloni L; Barresi S; Mastronuzzi A; Petruzzi A; Tramacere I; Farinotti M; Gurrieri L; Pirola E; Scarpelli M; Lombardi G; Villani V; Simonelli M; Merli R; Salmaggi A; Tartaglia M; Silvani A; DiMeco F; Calistri D; Lamperti E; Locatelli F; Indraccolo S; Pollo B
    Cancer Lett; 2024 Apr; 588():216711. PubMed ID: 38423245
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 53.